. The data also shared that the vaccine was 100 percent effective at preventing severe cases of coronavirus.
According to Moderna, efficacy of the vaccine was consistent across age, race and ethnicity, and gender demographics. The company continues to monitor safety data, but since Nov. 16 when it shared that the only concerns were mild side effects including pain or redness at the injection site, fatigue, fever, muscle and joint pain, and headaches, no new serious safety concerns have been identified.
Moderna is just behind Pfizer and its German partner BioNTech, which over a week ago asked FDA regulators to. The vaccine also requires two doses per person, and Pfizer said it can produce up to 50 million doses this year with about half going to the United States. Anthony Fauci, MD, director of the National Institute of Allergies and Infectious Diseases, projects that both vaccines will be
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.